Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03546673 · ClinicalTrials.gov registry record · NA
Health Benefits of Expressive Writing: Study One
A NA study, sponsored by University of Houston.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT03546673: Completed NA study, sponsored by University of Houston.
NCT03546673 is a NA study that has completed, run by University of Houston. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03546673, a NA study, has completed, sponsored by University of Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
This study is a randomized controlled trial (RCT) with the aim of determining the cultural sensitivity, feasibility, and effectiveness of an expressive writing intervention for Chinese breast cancer survivors.
Primary Outcome
The Functional Assessment of Cancer Therapy Scale (FACT) is a 27-item measure of health-related quality of life (Cella \& Tulsky,1993), which assesses perceived life quality in four different facets, including physical well-being (7 items), social well-being (7 items), emotional well-being (6 items), and functional wellbeing (7 items).
Interventions
- BEHAVIORAL Self-Regulation Condition
- BEHAVIORAL Emotional Disclosure Condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2009-07 |
| Est. Completion | 2011-10 |
| Phase | NA |
What the finished NCT03546673 record still lists
NCT03546673 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Self-Regulation Condition is the first listed.
NCT03546673 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03546673 about?
NCT03546673 is a clinical study titled "Health Benefits of Expressive Writing: Study One". This study is a randomized controlled trial (RCT) with the aim of determining the cultural sensitivity, feasibility, and effectiveness of an expressive writing intervention for Chinese breast cancer survivors.
What is the current status of trial NCT03546673?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2009-07. Estimated completion is 2011-10.
What interventions are being tested in trial NCT03546673?
The interventions under investigation include: Self-Regulation Condition (BEHAVIORAL), Emotional Disclosure Condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT03546673?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03546673's enrollment target sits among peer trials
96 925th of 2000 higher than 1,070 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia